CDW Corp Stock Price, News & Analysis

CDW (Nasdaq: CDW) announced a significant expansion of its shareholder return program, including a $750 million increase to its share repurchase authorization and a quarterly cash dividend declaration of $0.625 per share. The dividend represents a 1% increase from the previous year and will be paid on March 11, 2025, to stockholders of record as of February 25, 2025.

The new repurchase authorization adds to approximately $588 million remaining from the previous program as of December 31, 2024. Since its IPO in June 2013, CDW has returned over $7.2 billion to stockholders through dividends and share repurchases, with the dividend growing nearly fifteen-fold from its initial level.

CDW (Nasdaq:CDW) reported its Q4 and full-year 2024 results. Q4 net sales increased 3.3% to $5,186 million, while full-year sales decreased 1.8% to $20,999 million. Q4 net income declined 10.8% to $264.2 million, with earnings per diluted share at $1.97, down 9.8% from the previous year.

The company's Board approved a $750 million increase to its share repurchase authorization and declared a quarterly cash dividend of $0.625 per share, representing a 1% increase year-over-year. Despite challenging market conditions, CDW saw improvements in certain end-markets during Q4, with Healthcare customers showing particularly strong growth of 29.5%.

Gross profit margin in Q4 was 22.3%, down from 23.0% in Q4 2023, while full-year gross profit margin remained stable at 21.9%. The company maintains its target of exceeding US IT market growth by 200-300 basis points for 2025.

Medexus Pharmaceuticals announces FDA approval of GRAFAPEX (treosulfan), an alkylating agent used with fludarabine for allogeneic hematopoietic stem cell transplantation in AML or MDS patients. The drug holds Orphan Drug Designation, providing up to 7.5 years of regulatory exclusivity.

The company targets commercial launch in first half of 2025, projecting annual product-level revenue to exceed $100 million within five years. A $15 million regulatory milestone payment to medac GmbH will be made in installments: $2.5M by June 2025, $5M by October 2025, and $7.5M by January 2026.

Preliminary Q3 2025 estimates show revenue between $29.5-30.5 million (17% YoY increase), Adjusted EBITDA of $5.5-6.0 million (70% YoY increase), and operating income of $3.5-4.0 million (123% YoY increase). The company reports $8.5 million in available liquidity as of December 31, 2024.

CDW (Nasdaq: CDW), a leading multi-brand provider of information technology solutions, has announced it will host a webcast conference call to discuss its fourth quarter and full year 2024 results on Wednesday, February 5, 2025, at 7:30 a.m. CT/8:30 a.m. ET.

The live webcast, which will include audio and slides, will be accessible at investor.CDW.com. The company will post the press release and presentation slides on the website before the call. Investors are advised to register and download necessary software at least fifteen minutes before the call. A recorded replay will be available on the website after the event.

Great Hill Partners has announced the sale of Mission Cloud Services to CDW (NASDAQ: CDW). Mission Cloud Services, founded in partnership with Simon Anderson, has grown to become the largest independent AWS managed services company in the United States. The company specializes in cloud professional services, managed services, and consulting, particularly for Amazon Web Services customers. As an AWS-certified generative AI partner, Mission offers AI and Machine Learning solutions with comprehensive protection for AWS-managed environments. Great Hill Partners initially invested in Mission in 2017 and strengthened its market position through three strategic technology company acquisitions from 2017-2019.

CDW has acquired Mission Cloud Services, an AWS Premier Tier Partner specializing in cloud professional services, managed services, and consulting. The acquisition enhances CDW Digital Velocity's cloud, data, AI, and software platform engineering capabilities. Mission, founded in 2017, will become CDW's dedicated AWS practice, bringing expertise in customized solutions for small business and mid-market AWS customers. As an AWS-certified generative AI partner, Mission offers AI/ML solutions and security services for AWS environments. The merger combines their AWS expertise, with a total of 17 AWS Competencies.

CDW (Nasdaq: CDW) announced that its CEO Christine A. Leahy and CFO Albert J. Miralles will participate in a Q&A session at the UBS Global Technology and AI Conference. The event will take place at The Phoenician in Scottsdale, Arizona on December 3, 2024, at 10:35 a.m. CT. The session will be webcast live on investor.cdw.com, with the recording available for 180 days after the event. CDW is a leading multi-brand provider of IT solutions serving business, government, education, and healthcare customers across the US, UK, and Canada.

CDW Canada's new research reveals significant unauthorized use of Generative AI (GenAI) tools in Canadian workplaces. The study shows 47 percent of Canadian workers are using unregulated AI tools, with 33 percent using them weekly. Employee confidence in AI increases when organizations take the lead, with 61 percent feeling comfortable when tools are officially implemented.

The research highlights that mid and senior-level employees are the primary users of unapproved GenAI tools, with 38 percent and 37 percent respectively using them without approval. While 36 percent of organizations plan to implement AI tools, 73 percent haven't sought third-party support, putting pressure on internal IT teams.

CDW has announced a quarterly cash dividend increase of 1% to $0.625 per share, payable on December 10, 2024, to stockholders of record as of November 25, 2024. The dividend aligns with the company's target of 25% of trailing-twelve-month Non-GAAP net income through September 30, 2024. Since its IPO in 2013, CDW's dividend has grown nearly fifteen-fold with eleven consecutive years of increases. The company has returned approximately $6.9 billion to stockholders through share repurchases and dividends.